Stock listing
NASDAQ:VBIO Valion Bio, Inc. Stock
Home listing (NASDAQ) of Valion Bio, Inc.
Follow Valion Bio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VBIO
$0.55 USD -0.07 (-10.8%)
Close on Oct 30, 2026
- Day range
- $0.524 – $0.603 USDOct 30, 2026
- Volume
- 216,589 sharesOct 30, 2026
- Market cap
- $1.15M USDAt the close on Oct 30, 2026 · price × 2.10M shares outstanding
- 52-week range
- $0.524 – $67.50 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.70M USDMedian day 139,650 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VBIO · Home | $0.55 USD | -0.067 (-10.8%) | 216,589 | $0.60 | $0.603 | $0.524 | $0.617 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:VBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.55 | -0.067 | -10.8% | $0.60 | $0.603 | $0.524 | 216,589 | |
| $0.617 | -0.062 | -9.1% | $0.65 | $0.702 | $0.616 | 138,048 | |
| $0.679 | -0.103 | -13.2% | $0.763 | $0.77 | $0.663 | 525,562 | |
| $0.782 | -0.058 | -6.9% | $0.752 | $0.87 | $0.75 | 316,249 | |
| $0.84 | -0.10 | -10.6% | $0.88 | $0.89 | $0.68 | 17,366,069 | |
| $0.94 | -0.016 | -1.7% | $0.91 | $0.956 | $0.90 | 41,700 | |
| $0.956 | -0.164 | -14.6% | $1.10 | $1.10 | $0.931 | 173,600 | |
| $1.12 | -0.07 | -5.9% | $1.20 | $1.20 | $1.10 | 201,700 | |
| $1.19 | +0.03 | +2.6% | $1.12 | $1.26 | $1.11 | 59,400 | |
| $1.16 | -0.01 | -0.9% | $1.11 | $1.20 | $1.045 | 130,100 | |
| $1.17 | -0.06 | -4.9% | $1.23 | $1.24 | $1.13 | 270,600 | |
| $1.23 | -0.22 | -15.2% | $1.11 | $1.33 | $1.11 | 13,726,600 | |
| $1.45 | -0.10 | -6.5% | $1.54 | $1.55 | $1.435 | 160,100 | |
| $1.55 | -0.13 | -7.7% | $1.68 | $1.68 | $1.47 | 179,200 | |
| $1.68 | -0.46 | -21.5% | $2.10 | $2.14 | $1.59 | 248,600 | |
| $2.14 | -0.07 | -3.2% | $2.19 | $2.27 | $2.10 | 140,000 | |
| $2.21 | +0.02 | +0.9% | $2.07 | $2.28 | $2.07 | 150,900 | |
| $2.19 | -0.19 | -8.0% | $2.31 | $2.38 | $2.18 | 125,500 | |
| $2.38 | -0.10 | -4.0% | $2.36 | $2.48 | $2.33 | 128,300 | |
| $2.48 | -0.11 | -4.2% | $2.42 | $2.49 | $2.30 | 309,800 | |
| $2.59 | +0.08 | +3.2% | $2.55 | $2.69 | $2.456 | 237,600 | |
| $2.51 | -0.29 | -10.4% | $2.55 | $2.75 | $2.48 | 674,700 | |
| $2.80 | -0.03 | -1.1% | $4.00 | $4.39 | $2.53 | 52,286,800 | |
| $2.83 | +0.13 | +4.8% | $2.63 | $3.118 | $2.41 | 376,600 | |
| $2.70 | -0.33 | -10.9% | $2.82 | $3.03 | $2.65 | 219,900 | |
| $3.03 | -0.45 | -12.9% | $3.34 | $3.499 | $2.79 | 751,800 | |
| $3.48 | +0.75 | +27.5% | $2.62 | $3.79 | $2.32 | 10,751,400 | |
| $2.73 | +0.24 | +9.6% | $2.45 | $3.29 | $2.254 | 2,109,200 | |
| $2.49 | +0.11 | +4.6% | $2.41 | $2.80 | $2.36 | 536,100 | |
| $2.38 | +0.26 | +12.3% | $2.138 | $2.45 | $2.133 | 122,700 | |
| $2.12 | -0.11 | -4.9% | $2.29 | $2.36 | $2.12 | 56,900 | |
| $2.23 | +0.15 | +7.2% | $2.16 | $2.44 | $2.12 | 216,400 | |
| $2.08 | -0.03 | -1.4% | $2.05 | $2.26 | $2.05 | 114,700 | |
| $2.11 | +0.01 | +0.5% | $2.12 | $2.17 | $2.059 | 33,900 | |
| $2.10 | -0.16 | -7.1% | $2.25 | $2.42 | $2.10 | 146,600 | |
| $2.26 | +0.06 | +2.7% | $2.19 | $2.39 | $2.17 | 161,000 | |
| $2.20 | -0.20 | -8.3% | $2.38 | $2.38 | $2.158 | 76,500 | |
| $2.40 | -0.10 | -4.0% | $2.26 | $2.47 | $2.22 | 122,100 | |
| $2.50 | -0.27 | -9.7% | $2.74 | $2.74 | $2.44 | 159,500 | |
| $2.77 | -0.03 | -1.1% | $2.90 | $2.989 | $2.72 | 71,500 | |
| $2.80 | -0.32 | -10.3% | $3.03 | $3.21 | $2.75 | 139,300 | |
| $3.12 | +0.05 | +1.6% | $3.02 | $3.239 | $2.70 | 148,200 | |
| $3.07 | -0.50 | -14.0% | $3.22 | $3.46 | $2.88 | 291,900 | |
| $3.57 | +0.545 | +18.0% | $2.80 | $3.87 | $2.80 | 663,100 | |
| $3.025 | -0.05 | -1.6% | $3.075 | $3.35 | $2.925 | 20,899 | |
| $3.075 | -0.825 | -21.2% | $3.80 | $3.875 | $2.925 | 13,009 | |
| $3.90 | -0.075 | -1.9% | $3.85 | $4.125 | $3.825 | 5,642 | |
| $3.975 | -0.175 | -4.2% | $3.625 | $4.075 | $3.50 | 11,678 | |
| $4.15 | +1.075 | +35.0% | $3.00 | $4.70 | $2.925 | 175,607 | |
| $3.075 | +0.025 | +0.8% | $2.975 | $3.30 | $2.80 | 6,250 | |
| $3.05 | -0.30 | -9.0% | $3.325 | $3.325 | $2.875 | 7,999 | |
| $3.35 | -0.675 | -16.8% | $3.30 | $3.425 | $2.825 | 19,884 | |
| $4.025 | -0.55 | -12.0% | $4.50 | $4.50 | $3.80 | 17,242 | |
| $4.575 | -0.20 | -4.2% | $4.30 | $5.975 | $4.175 | 43,919 | |
| $4.775 | +0.50 | +11.7% | $4.05 | $7.325 | $4.00 | 273,631 | |
| $4.275 | -1.375 | -24.3% | $4.00 | $5.125 | $3.975 | 37,776 | |
| $5.65 | -2.10 | -27.1% | $8.325 | $32.50 | $5.00 | 220,334 | |
| $7.75 | +0.55 | +7.6% | $7.20 | $8.925 | $7.025 | 2,209 | |
| $7.20 | +0.075 | +1.1% | $7.20 | $7.50 | $6.875 | 185 | |
| $7.125 | +0.25 | +3.6% | $7.075 | $8.325 | $6.575 | 1,806 | |
| $6.875 | -0.45 | -6.1% | $7.50 | $8.00 | $6.50 | 1,287 | |
| $7.325 | -0.975 | -11.7% | $8.375 | $8.575 | $7.125 | 512 | |
| $8.30 | +0.40 | +5.1% | $8.15 | $9.25 | $8.00 | 1,017 | |
| $7.90 | +0.15 | +1.9% | $8.125 | $8.80 | $7.25 | 1,381 | |
| $7.75 | +0.80 | +11.5% | $7.45 | $9.025 | $6.40 | 5,547 | |
| $6.95 | -0.05 | -0.7% | $6.65 | $6.975 | $6.275 | 221 |
- Ticker
- NASDAQ:VBIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
Latest earnings call · May 14, 2026
Valion Bio (NASDAQ:VBIO) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Jan 20, 2026
Tivic Health Systems — Investor Presentation (January 2026)
Investor deck · 18 slides
Calls
Replays
Valion Bio (NASDAQ:VBIO) Q1 2026 Earnings Call
Thu, May 14, 2026 · 5:00 PM ET
Watch TranscriptTivic Health Systems, Inc. (TIVC) Q4 2025 Earnings Call
Wed, Mar 25, 2026 · 4:30 PM ET
Watch TranscriptTivic Health Systems, Inc. (TIVC) Q3 2025 Earnings Call
Fri, Nov 14, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
Oct 30, 2026
Closed $0.55 (-10.8%) on Oct 30, 2026
Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation
Oct 28, 2026
Closed $0.679 (-13.2%) on Oct 28, 2026
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
Oct 26, 2026
Closed $0.84 (-10.6%) on Oct 26, 2026
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
Oct 21, 2026
Closed $1.12 (-5.9%) on Oct 21, 2026
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
Oct 15, 2026
Closed $1.23 (-15.2%) on Oct 15, 2026
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
Oct 14, 2026
Closed $1.45 (-6.5%) on Oct 14, 2026
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Sep 23, 2026
Closed $2.73 (+9.6%) on Sep 23, 2026
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
Sep 22, 2026
Closed $2.49 (+4.6%) on Sep 22, 2026
Valion Bio Announces Reverse Stock Split
Aug 27, 2026
Closed $3.07 (-21.2%) on Aug 27, 2026
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
Aug 12, 2026
Closed $5.65 (-27.1%) on Aug 12, 2026
Decks
Tivic Health Systems — Investor Presentation (January 2026)
Investor deck · 18 slides · Jan 20, 2026
Tivic Health Systems — Q1 2025 Earnings Presentation
Earnings · 16 slides · May 15, 2025
Tivic Health Systems — Investor Presentation (March 2025)
Investor deck · 11 slides · Mar 21, 2025
Tivic Health Systems — Investor Presentation (May 2024)
Investor deck · 19 slides · May 22, 2024
Valion Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 24 in all · newest Oct 30, 2026 · oldest 2026
- Calls
- 16 calls with a replay · 16 with a transcript · latest May 14, 2026
- Decks
- 10 decks · latest Jan 20, 2026
Where Valion Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VBIO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VBIO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Valion Bio, Inc.